Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Review of Anticancer Therapy
List of Issues
Volume 15, Issue 12

Expert Review of Anticancer Therapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Review of Anticancer Therapy, Volume 15, Issue 12 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Anticancer Therapy, Volume 15, Issue 12 (2015)

See all volumes and issues

Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Volume 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma

Francesco Massari, Chiara Ciccarese, Matteo Santoni, Antonio Lopez-Beltran, Marina Scarpelli, Rodolfo Montironi & Liang Cheng

Pages: 1367-1369

Published online: 14 Nov 2015

AbstractforTargeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma | Full Text | References | PDF (128.1 KB)

2135 Views
19 CrossRef citations
0Altmetric

Free Access

Drug Profiles

Article

Nab-paclitaxel in patients with metastatic melanoma

Roberto A Leon-Ferre & Svetomir N Markovic

Pages: 1371-1377

Published online: 04 Nov 2015

AbstractforNab-paclitaxel in patients with metastatic melanoma | Full Text | References | PDF (159.4 KB)

364 Views
8 CrossRef citations
0Altmetric

Article

Valrubicin in refractory non-muscle invasive bladder cancer

Pranav Sharma, Kamran Zargar-Shoshtari & Wade J. Sexton

Pages: 1379-1387

Published online: 16 Nov 2015

AbstractforValrubicin in refractory non-muscle invasive bladder cancer | Full Text | References | PDF (182.7 KB)

319 Views
8 CrossRef citations
0Altmetric

Article

Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1–derived oncolytic immunotherapy

Kevin J Harrington, Igor Puzanov, J. Randolph Hecht, F. Stephen Hodi, Zsolt Szabo, Swami Murugappan & Howard L Kaufman

Pages: 1389-1403

Published online: 03 Dec 2015

AbstractforClinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1–derived oncolytic immunotherapy | Full Text | References | PDF (782.3 KB)

11919 Views
94 CrossRef citations
0Altmetric

Free Access

Reviews

Drugs acting on homeostasis: challenging cancer cell adaptation

Maria Moschovi, Elena Critselis, Osman Cen, Maria Adamaki, George I Lambrou, George P Chrousos & Spiros Vlahopoulos

Pages: 1405-1417

Published online: 02 Nov 2015

AbstractforDrugs acting on homeostasis: challenging cancer cell adaptation | Full Text | References | PDF (662.5 KB)

209 Views
18 CrossRef citations
0Altmetric

Current challenges of lung cancer care in an aging population

Paola Claudia Sacco, Francesca Casaluce, Assunta Sgambato, Antonio Rossi, Paolo Maione, Giovanni Palazzolo, Alba Napolitano & Cesare Gridelli

Pages: 1419-1429

Published online: 15 Oct 2015

AbstractforCurrent challenges of lung cancer care in an aging population | Full Text | References | PDF (367.9 KB)

325 Views
6 CrossRef citations
0Altmetric

PET-directed therapy in Hodgkin lymphoma: Ready for prime time?

Timothy H Dorius, Nathan R Bennion & James O Armitage

Pages: 1431-1441

Published online: 15 Oct 2015

AbstractforPET-directed therapy in Hodgkin lymphoma: Ready for prime time? | Full Text | References | PDF (456.8 KB)

162 Views
1 CrossRef citations
0Altmetric

Optimal therapy for desmoid tumors: current options and challenges for the future

Mushriq Al-Jazrawe, Magdalene Au & Benjamin Alman

Pages: 1443-1458

Published online: 15 Oct 2015

AbstractforOptimal therapy for desmoid tumors: current options and challenges for the future | Full Text | References | PDF (315.5 KB)

687 Views
29 CrossRef citations
0Altmetric

The evolving role of radiotherapy in treatment of oligometastatic NSCLC

Derek P. Bergsma, Joseph K Salama, Deepinder P. Singh, Steven J Chmura & Michael T. Milano

Pages: 1459-1471

Published online: 04 Nov 2015

AbstractforThe evolving role of radiotherapy in treatment of oligometastatic NSCLC | Full Text | References | PDF (209 KB)

474 Views
6 CrossRef citations
0Altmetric

Massive parallel sequencing in sarcoma pathobiology: state of the art and perspectives

Monica Brenca & Roberta Maestro

Pages: 1473-1488

Published online: 04 Nov 2015

AbstractforMassive parallel sequencing in sarcoma pathobiology: state of the art and perspectives | Full Text | References | PDF (334.2 KB)

301 Views
9 CrossRef citations
0Altmetric

Advanced dual-energy CT for head and neck cancer imaging

Reza Forghani

Pages: 1489-1501

Published online: 04 Nov 2015

AbstractforAdvanced dual-energy CT for head and neck cancer imaging | Full Text | References | PDF (903 KB)

491 Views
27 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancer

Renata Pacholczak-Madej et al.

Review Article | Published online: 12 Jun 2024

Relacorilant in recurrent ovarian cancer: clinical evidence and future perspectives

Elena Giudice et al.

Review Article | Published online: 11 Jun 2024

Open Access

Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?

Lorenzo Foffano et al.

Comment | Published online: 10 Jun 2024

Adenoid Cystic carcinoma of minor salivary glands (AdCCmSG): a multidisciplinary update

Rebecca Romanò et al.

Review Article | Published online: 4 Jun 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Review of Anticancer Therapy (Vol.15, Iss.12, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?